1. Circulating ghrelin levels in patients with inflammatory bowel disease. Issue 3 (10th February 2006) Authors: Peracchi, M; Bardella, M T; Caprioli, F; Massironi, S; Conte, D; Valenti, L; Ronchi, C; Beck-Peccoz, P; Arosio, M; Piodi, L Journal: Gut Issue: Volume 55:Issue 3(2006) Page Start: 432 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21. Issue 12 (8th May 2006) Authors: Monteleone, G; Caruso, R; Fina, D; Peluso, I; Gioia, V; Stolfi, C; Fantini, M C; Caprioli, F; Tersigni, R; Alessandroni, L; MacDonald, T T; Pallone, F Journal: Gut Issue: Volume 55:Issue 12(2006) Page Start: 1774 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. DOP21 Potential mechanisms linking biological therapies on SARS-CoV-2 susceptibility in Inflammatory Bowel Disease patients. (21st January 2022) Authors: Pisani, L F; Mola, S; Crespi, G; Caprioli, F; Pastorelli, L; Annunziata, M L; Manfredi, M; Porta, C Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i070 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Issue 11 (30th June 2009) Authors: Iliev, I D; Spadoni, I; Mileti, E; Matteoli, G; Sonzogni, A; Sampietro, G M; Foschi, D; Caprioli, F; Viale, G; Rescigno, M Journal: Gut Issue: Volume 58:Issue 11(2009) Page Start: 1481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long‐Term Safety ofIn UteroExposure to Anti‐TNFα Drugs for the Treatment of Inflammatory Bowel Disease: Results from the Multicenter European TEDDY Study. (March 2018) Authors: Chaparro, M; Verreth, A; Lobaton, T; Gravito‐Soares, E; Julsgaard, M; Savarino, E; Magro, F; Biron, Avni I; Lopez‐Serrano, P; Casanova, M J; Gompertz, M; Vitor, S; Arroyo, M; Pugliese, D; Zabana, Y; Vicente, R; Aguas, M; Shitrit, Bar‐Gil A; Gutierrez, A; Doherty, G A Journal: American journal of gastroenterology Issue: Volume 113:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P107 IL10 secretion endows intestinal human iNKT cells with regulatory functions towards pathogenic T lymphocytes in Crohn's disease patients. (21st January 2022) Authors: Burrello, C; Strati, F; Diaz-Basabe, A; Lattanzi, G; Lopez, G; Trombetta, E; Conforti, F S; Botti, F; Vecchi, M; Fantini, M C; Caprioli, F; Facciotti, F Journal: Journal of Crohn's and colitis Issue: Volume 16(2022)Supplement 1 Page Start: i201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P161 The impact of biologic therapies on Extra-Intestinal Manifestations in Inflammatory Bowel Disease: a multicentre observational study. (27th May 2021) Authors: Ferretti, F; Monico, M C; Cannatelli, R; Lenti, M V; Di Sabatino, A; Carmagnola, S; Conforti, F; Pastorelli, L; Caprioli, F; Bezzio, C; Saibeni, S; Mazza, S; Vecchi, M; Maconi, G; Ardizzone, S Journal: Journal of Crohn's and colitis Issue: Volume 15(2021)Supplement 1 Page Start: S239 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P237 Superior predictive value of intestinal ultrasound over endoscopic severity for colectomy risk in patients with ulcerative colitis. (30th January 2023) Authors: Piazza, N; Noviello, D; Filippi, E; Conforti, F; Furfaro, F; Fraquelli, M; Fiorino, G; Danese, S; Allocca, M; Caprioli, F Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i390 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P423 Effect of tofacitinib on colectomy risk in anti TNF-alfa refractory ulcerative colitis. (30th January 2023) Authors: Romeo, S; Carvalhas Gabrielli, A M; Ferretti, F; Piazza O Sed, N; Mazzola, A M; Alicante, S; Berté, R; Scribano, M L; Buscarini, E; Ricci, C; Caprioli, F; Ardizzone, S; Cannatelli, R Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i552 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. P433 Efficacy of risankizumab by baseline clinical, biochemical, and endoscopic disease severity in moderately to severely active Crohn's disease. (30th January 2023) Authors: Panaccione, R; D'Haens, G; Seenan, J P; Caprioli, F; Siegel, C; Nakamura, M; Wei, S C; Kligys, K; Zhang, Y; Zambrano, J; Song, A P; Ferrante, M Journal: Journal of Crohn's and colitis Issue: Volume 17(2023)Supplement 1 Page Start: i560 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗